LyondellBasell Industries N.V.
For the period ended Dec 31, 2025. Filed Feb 20, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 20, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Equity Investments
- Equity Investments
Our significant equity investments are as follows at December 31:
| Percent of Ownership | 2025 | 2024 |
|---|---|---|
| Olefins and Polyolefins-Americas | ||
| Louisiana Joint Venture | 50.00% | 50.00% |
| Indelpro S.A. de C.V. | 49.00% | 49.00% |
| Olefins and Polyolefins-Europe, Asia, International | ||
| Basell Orlen Polyolefins Sp. Z.o.o. | 50.00% | 50.00% |
| PolyMirae Co. Ltd. | 50.00% | 50.00% |
| Bright LyondellBasell Petrochemical Co. Ltd. | 50.00% | 50.00% |
| National Petrochemical Industrial Company | 35.00% | 35.00% |
| HMC Polymers Company Ltd. | 28.56% | 28.56% |
| Al-Waha Petrochemicals Ltd. | 25.00% | 25.00% |
| Saudi Ethylene & Polyethylene Company Ltd. | 25.00% | 25.00% |
| Saudi Polyolefins Company | 25.00% | 25.00% |
| Intermediates and Derivatives | ||
| U.S. PO Joint Venture | 60.62% | 60.62% |
| European PO JV | 50.00% | 50.00% |
| Ningbo ZRCC Lyondell Chemical Co. Ltd. | 26.65% | 26.65% |
The following table summarizes changes in our equity investments:
| Year Ended December 31, | ||
|---|---|---|
| Millions of dollars | 2025 | 2024 |
| Beginning balance | $4,121 | $3,907 |
| Capital contributions | 25 | 113 |
| Loss from equity investments | (12) | (217) |
| Acquisition of equity investments | 14 | 551 |
| Distribution of earnings, net of tax | (92) | (122) |
| Depreciation of PO Joint Ventures and Louisiana Joint Venture | (125) | (118) |
| Impairments | (4) | (13) |
| Currency exchange effects | 46 | (26) |
| Other | (10) | 46 |
| Ending balance | $3,963 | $4,121 |
Capital contributions in 2025 and 2024 include $4 million and $84 million, respectively, related to our PO Joint Ventures.
Closure of European PO Joint Venture—In March 2025, we announced the permanent closure of our European PO Joint Venture. We will carry out a process to safely shut down and prepare for the demolition of the asset. We estimate our portion of the total shutdown costs will be approximately $215 million and will be incurred through 2027. We incurred shutdown costs of $126 million during the year ended December 31, 2025. These costs are included in Cost of Sales in the Consolidated Statements of Income (Loss).
Acquisition of Joint Venture Interest—In May 2024, we acquired a 35% interest in Saudi Arabia-based National Petrochemical Industrial Company from Alujain Corporation for approximately $500 million. The joint venture currently has the capacity to produce 400 thousand tons of polypropylene per year. We market the majority of the off-take through our global sales team. The joint venture is included in our O&P-EAI segment and accounted for using the equity method of accounting.
Impairments—During the fourth quarter of 2023, we recognized a non-cash impairment charge of $192 million related to our European PO Joint Venture due to a trend of negative financial performance and the unfavorable long-term economic outlook for the joint venture. The fair value of our investment was determined using an income approach and the significant inputs used in our fair value determination, including projected cash flows and the discount rate, are considered Level 3. This charge is reflected as Other impairments in the Consolidated Statements of Income (Loss).
Summarized balance sheet information of our investments accounted for under the equity method (presented on a 100% basis) at December 31 is as follows:
| Millions of dollars | 2025 | 2024 |
|---|---|---|
| Current assets | $2,826 | $3,230 |
| Noncurrent assets | 8,553 | 8,517 |
| Total assets | 11,379 | 11,747 |
| Current liabilities | 1,549 | 1,637 |
| Noncurrent liabilities | 1,414 | 1,064 |
| Net assets | $8,416 | $9,046 |
As of December 31, 2025 and 2024, the carrying value of our equity method investments exceeded the underlying net assets of our investees by $554 million and $557 million, respectively. Amortization of the basis difference is included in Loss from equity investments and is not material.
Summarized income statement information of our investments accounted for under the equity method (presented on a 100% basis) is as follows:
| Year Ended December 31, | |||
|---|---|---|---|
| Millions of dollars | 2025 | 2024 | 2023 |
| Revenues | $8,862 | $13,113 | $12,540 |
| Cost of sales | (8,534) | (12,669) | (12,044) |
| Gross profit | 328 | 444 | 496 |
| Net operating expenses | (856) | (614) | (514) |
| Operating loss | (528) | (170) | (18) |
| Interest income | 24 | 26 | 23 |
| Interest expense | (53) | (148) | (131) |
| Foreign currency translation | 3 | (17) | (1) |
| Other expense, net | (5) | (3) | (23) |
| Loss before income taxes | (559) | (312) | (150) |
| (Provision for) benefit from income taxes | (61) | (252) | 22 |
| Net loss | $(620) | $(564) | $(128) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.